口服疫苗给药系统的研究进展
作者：陈浮;张志荣;黄园;
Author：
收稿日期： 年卷（期）页码：2007,(01):-69-71
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：口服疫苗;给药系统;研究进展
Key words：
基金项目：
中文摘要
综述微粒口服疫苗给药系统、生物黏附和pH敏感给药系统以及靶向给药系统的研究进展。
参考文献
[1]Friede M,Aguado MT.Need for new vaccine formulations andpotential of particulate antigen and DNA delivery systems[J].Adv Drug Deliv Rev,2005,57:325-331.
[2]Jung T,Kamm W,Breitenbach A,et al.Biodegradable nanop-articles for oral delivery of peptides:is there a role for polymersto affect mucosal uptake[J].Eur J Pharm Biopharm,2000,50:147-160.
[3]Monjed Shakweh,Madeleine Besnard,Vale′rie Nicolas,et al.Poly(lactide-co-glycolide)particles of different physicochem-ical properties and their uptake by peyer’s patches in mice[J].Eur J Pharm Biopharma,2005,61:1-13.
[4]Sudhir PK,Karishma S,Krishnendu R.Covalent conjugation ofpolyethyleneimine on biodegradable microparticles for delivery ofplasmid DNA vaccines[J].Biomaterials,2005,26:6375?6385.
[5]Jung T,Koneberg R,Hungerer KD,et al.Tetanus toxoid micro-spheres consisting of biodegradable poly(lactide-co-glycolide)-and ABA-triblock-copolymers:immune response in mice[J].Int J Pharm,2002,234:75-90.
[6]Alpar HO,Somavarapu S,Atuah KN,et al.Biodegradable mu-coadhesive particulates for nasal and pulmonary antigen and DNAdelivery[J].Adv Drug Deliv Rev,2005,57:411-430.
[7]van der Lubben IM,Verhoef JC,Borchard G,et al.Chitosan formucosal vaccination[J].Adv Drug Deliv Rev,2001,52:139-144.
[8]Vila A,Sa′nchez A,Tobio M,et al.Design of biodegradableparticles for protein delivery[J].J Control Release,2002,78:15-24.
[9]Thanou M,Verhoef JC,Junginger HE.Oral drug absorption en-hancement by chitosan and its derivatives[J].Adv Drug DelivRev,2001,52:117-126.
[10]Snyman D,Hamman JH,Kotze′AF.Evaluation of the mucoad-hesive properties of N-trimethyl chitosan chloride[J].DrugDev Ind Pharm,2003,29:59-67.
[11]陈浮,张志荣,黄园.尿素酶三甲基聚糖亚微球的制备及其相关性质的初步研究[J].华西药学杂志,2006,22(1):12-14.
[12]Kockisch S,Rees GD,Young SA,et al.Polymeric microspheresfor drug delivery to the oral cavity:an in vitro evaluation of mu-coadhesive potential[J].J Pharm Sci,2003,92:1614-1623.
[13]Takeuchi H,Matsui Y,Yamamoto H,et al.Mucoadhesive prop-erties of carbopol or chitosan-coated liposomes and their effec-tiveness in the oral administration of calcitonin to rats[J].JControl Release,2003,86:235-242.
[14]Maria Joa o Lopes Gonc alves de Brito Amorim,Joa o PauloMedeiros Ferreira.Microparticles for delivering therapeutic pep-tides and proteins to the lumen of the small intestine[J].Eur JPharm Biopharma,2001,52:39-44.
[15]Hori M,Onishi H,Machida Y,et al.Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system[J].Int J Pharm,2005,297:223-234.
[16]Lamprecht A,Yamamoto H,Takeuchi H,et al.ApH-sensitivemicrosphere system for the colon delivery of tacrolimus containingnanoparticles[J].J Control Release,2005,104:337-346.
[17]Dai J,Nagai T,Wong X,et al.pH-sensitive nanoparticles forimproving the oral bioavailability of cyclosporine A[J].Int JPharm,2004,280:229-240.
[18]Eldridge JH,Hammond CJ,Meulbroek JA,et al.Controlledvaccine release in the gut associated lymphoid tissues.I.Orallyadministered biodegradable microspheres target the Peyer’s pat-ches[J].J Control Release,1990,11:205-214.
[19]Harokopakis E,Hajishengallis G,Michalek SM.Effectiveness ofliposomes possessing surface-linked recombinant B subunit ofcholera toxin as an oral antigen delivery system[J].Infect Im-mun,1998,66:4299-4304.
[20]Clark MA,Blair H,Liang L,et al.Targeting polymerized lipo-some vaccine carriers to intestinal Mcells[J].Vaccine,2001,20:208-217.
[21]Lambkin I,Pinilla C,Hamashin C,et al.Towards targeted oralvaccine delivery systems:selection of lectin mimetics fromcombi-natorial libraries[J].Pharm Res,2003,20:1258-1266.
[22]Brayden,David J,Jepson,et al.Keynote review:Intestinal Pey-er’s patch Mcellsand oral vaccine targeting[J].Drug DiscoveryToday,2005,10:1145-1157.
[23]Brayden DJ,Baird AW.Apical membrane receptors on intestinalMcells:potential targets for vaccine delivery[J].Adv Drug De-liv Rev,2004,56:721-726.
【关闭】
